[[Is the PCA3 cost-effective in Latin America and the Caribbean?]]

Autor:	José Antonio Grández-Urbina, Rafael Pichardo-Rodríguez, Jorge Saldaña-Gallo
Rok vydání:	2018
Předmět:	Male lcsh:Public aspects of medicine Cost-Benefit Analysis Prostatic Neoplasms lcsh:RA1-1270 Adenocarcinoma Sensitivity and Specificity Neoplasm Proteins Latin America Caribbean Region Antigens Neoplasm Biomarkers Tumor Humans Developing Countries Early Detection of Cancer
Zdroj:	Salud Pública de México, Vol 60, Iss 1, ene-feb, Pp 104-105 (2017)
ISSN:	1606-7916
Popis:	[Not available]
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::216a3ca314012fe0662e6593e7a98fe0 https://pubmed.ncbi.nlm.nih.gov/29689669 Zobrazit plný text záznamu